AU Stock MarketDetailed Quotes

ILA Island Pharmaceuticals Ltd

Watchlist
  • 0.070
  • 0.0000.00%
20min DelayMarket Closed Jul 4 14:28 AET
8.87MMarket Cap-2187P/E (Static)

Island Pharmaceuticals Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
Total revenue
11.07K
Operating revenue
--11.07K
----
----
Cost of revenue
Gross profit
11.07K
Operating expense
3.53%2.91M
31.33%2.81M
2.14M
Selling and administrative expenses
0.34%1.6M
-15.90%1.6M
--1.9M
-General and administrative expense
0.34%1.6M
-15.90%1.6M
--1.9M
Research and development costs
10.77%1.14M
39,690.42%1.03M
--2.59K
Other operating expenses
-9.57%162.77K
-23.30%180K
--234.7K
Operating profit
-3.13%-2.9M
-31.33%-2.81M
-2.14M
Net non-operating interest income (expenses)
-9K
Non-operating interest expense
--9K
----
----
Other net income (expenses)
-62.59%75.62K
1,558.34%202.12K
12.19K
Other non-operating income (expenses)
-62.59%75.62K
1,558.34%202.12K
--12.19K
Income before tax
-8.58%-2.83M
-22.58%-2.61M
-2.13M
Income tax
0
0
0
Earnings from equity interest net of tax
Net income
-8.58%-2.83M
-22.58%-2.61M
-2.13M
Net income continuous operations
-8.58%-2.83M
-22.58%-2.61M
---2.13M
Noncontrolling interests
Net income attributable to the company
-8.58%-2.83M
-22.58%-2.61M
-2.13M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-8.58%-2.83M
-22.58%-2.61M
-2.13M
Diluted earnings per share
-8.07%-0.0323
71.78%-0.0299
-0.106
Basic earnings per share
-8.07%-0.0323
71.78%-0.0299
-0.106
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2023(FY)Jun 30, 2022(FY)Jun 30, 2021
Total revenue 11.07K
Operating revenue --11.07K--------
Cost of revenue
Gross profit 11.07K
Operating expense 3.53%2.91M31.33%2.81M2.14M
Selling and administrative expenses 0.34%1.6M-15.90%1.6M--1.9M
-General and administrative expense 0.34%1.6M-15.90%1.6M--1.9M
Research and development costs 10.77%1.14M39,690.42%1.03M--2.59K
Other operating expenses -9.57%162.77K-23.30%180K--234.7K
Operating profit -3.13%-2.9M-31.33%-2.81M-2.14M
Net non-operating interest income (expenses) -9K
Non-operating interest expense --9K--------
Other net income (expenses) -62.59%75.62K1,558.34%202.12K12.19K
Other non-operating income (expenses) -62.59%75.62K1,558.34%202.12K--12.19K
Income before tax -8.58%-2.83M-22.58%-2.61M-2.13M
Income tax 000
Earnings from equity interest net of tax
Net income -8.58%-2.83M-22.58%-2.61M-2.13M
Net income continuous operations -8.58%-2.83M-22.58%-2.61M---2.13M
Noncontrolling interests
Net income attributable to the company -8.58%-2.83M-22.58%-2.61M-2.13M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -8.58%-2.83M-22.58%-2.61M-2.13M
Diluted earnings per share -8.07%-0.032371.78%-0.0299-0.106
Basic earnings per share -8.07%-0.032371.78%-0.0299-0.106
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
AU
Overall
Symbol
Latest Price
%Chg